Unlocking the Potential of Ribosomal Protein L10 Pseudogene 13 as a Drug Target or Biomarker

Target Name: RPL10P13

NCBI ID: G390345

RPL10P13

Other Name(s): Ribosomal protein L10 pseudogene 13 | ribosomal protein L10 pseudogene 13

Unlocking the Potential of Ribosomal Protein L10 Pseudogene 13 as a Drug Target or Biomarker

Introduction

Ribosomal protein L10 pseudogene 13 (RPL10P13) is a non-coding RNA molecule that is primarily expressed in the nuclei of eukaryotic cells. It is a key component of the ribosome, the site of protein synthesis, and has been implicated in various cellular processes. The identification and characterization of RPL10P13 as a potential drug target or biomarker has significant implications for the development of new therapeutic strategies.

Drug Target

RPL10P13 has been identified as a potential drug target due to its unique structure and bioavailability. It is a small non-coding RNA molecule that can be easily synthesized and purified. Additionally, its expression is highly sensitive to various factors, such as growth conditions and drugs, which makes it an attractive candidate for drug screening.

The protein encoded by RPL10P13 has multiple functions, including the regulation of protein synthesis, DNA replication, and cell growth. It plays a critical role in the regulation of cellular processes that are crucial for human health and development. The alteration of RPL10P13 expression levels has has been observed in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Biomarker

RPL10P13 can also be used as a biomarker for various diseases. Its expression is affected by various factors, including growth conditions, drugs, and environmental factors. Therefore, the expression levels of RPL10P13 can be used as an indicator of disease status, disease severity, and response to treatment.

The discovery of RPL10P13 as a biomarker has significant implications for the development of new diagnostic tools and therapeutic strategies. It may also be used to monitor disease progression and response to treatment in patients.

Pathology

RPL10P13 is involved in various cellular processes that are essential for human health and development. Its expression is regulated by various factors, including DNA replication, RNA transcription, and protein synthesis. It plays a critical role in the regulation of gene expression, cell growth, and DNA replication.

In addition, RPL10P13 is involved in the regulation of protein synthesis, which is crucial for the development and maintenance of cellular structures and functions. The alteration of RPL10P13 expression levels has been observed in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Molecular Mechanisms

The molecular mechanisms underlying the regulation of RPL10P13 expression are not well understood. However, various studies have identified key players in its regulation, including DNA replication factors, RNA polymerases, and protein synthesis factors.

One of the key regulators of RPL10P13 expression is the DNA replication complex, which includes the protein replication factor DNA polymerase I (DNA2) and the DNA replication initiator complex (DNA2H0). The DNA polymerase I is responsible for copying the double-stranded DNA template , while DNA2H0 facilitates the access of the DNA template to the active site of DNA polymerase I.

Another key regulator of RPL10P13 expression is the RNA polymerase II (RNA2), which is responsible for transcribing the DNA template into RNA. The RNA2 has been shown to play a critical role in the regulation of RPL10P13 expression by binding to its promoter region and modulating its levels.

Additionally, various studies have identified a role for protein synthesis factors, such as the transcription factor p53 and the protein translation factor

Protein Name: Ribosomal Protein L10 Pseudogene 13

The "RPL10P13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL10P13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets